Vaccines (Aug 2021)

Evaluation of <i>Streptococcus uberis</i> Surface Proteins as Vaccine Antigens to Control <i>S. uberis</i> Mastitis in Dairy Cows

  • Oudessa Kerro Dego,
  • Raul Almeida,
  • Susan Ivey,
  • Getahun E. Agga

DOI
https://doi.org/10.3390/vaccines9080868
Journal volume & issue
Vol. 9, no. 8
p. 868

Abstract

Read online

There is no effective vaccine against Streptococcus uberis mastitis in dairy cows. Objectives of this study were (1) to extract S. uberis surface proteins (SUSP) and determine immunoreactivity in vitro and (2) immunogenicity and efficacy in vivo. SUSP was extracted from S. uberis, and their immunoreactivity was tested by western blot. In total, 26 Jersey dairy cows were randomly divided into four groups. Groups 1, 2, and 3 were vaccinated subcutaneously with 4 mg, 1 mg, and 100 μg of SUSP, respectively, with Freund’s incomplete adjuvant. Group 4 (control) was injected with placebo. S. uberis UT888 was infused into two contralateral quarters of each cow during early lactation. Somatic cell count (SCC), bacteria count in milk, and mastitis were monitored. Our results show that SUSP contains multiple protein bands, that ranged from 10 to 100 kDa. All vaccinates showed an increased anti-SUSP IgG antibody. The SCC of all experimentally infected quarters increased after challenge but slightly decreased after day 3 with no significant difference among groups. Milk bacterial count was significantly (p S. uberis mastitis.

Keywords